PsichogiouMKapeliosCJKonstantonisG. Prevalence, incidence, and contributors of subclinical atheromatosis, arteriosclerosis, and arterial hypertrophy in hiv-infected individuals: a single-center, 3-year prospective study. Angiology. 2019;70(5):448–57.
2.
GibelliniDBorderiMClòA. HIV-related mechanisms in atherosclerosis and cardiovascular diseases. J Cardiovasc Med (Hagerstown). 2013;14(11):780–90.
3.
ÜnalSYaylaÇAçarB. Tp-e interval and Tp-e/QT ratio in patients with human immunodeficiency virus. J Infect Public Health. 2018;11(1):35–8.
4.
ErtemAGYaylaÇAçarB. Assessment of the atrial electromechanical properties of patients with human immunodeficiency virus: J Infect Public Health. 2017;10(6):721–4.
5.
KontomanolisENMichalopoulosSGkasdarisGFasoulakisZ. The social stigma of HIV-AIDS: society’s role. HIV AIDS (Auckl). 2017;9:111–8.
